Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion

Summary. Background: Radical cystectomy (RC) has been used for over 100 years as an effective treatment of muscle invasive bladder cancer (MIBC). However, the main surgical challenge is not only to remove an affected organ but also to replace its functional component — urine divers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2023
Hauptverfasser: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Grechko, B.O., Voylenko, O.A., Kononenko, O.A., Vitruk, I.V., Stakhovsky, E.O.
Format: Artikel
Sprache:English
Veröffentlicht: PH Akademperiodyka 2023
Schlagworte:
Online Zugang:https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-10
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Experimental Oncology

Institution

Experimental Oncology
id oai:ojs2.ex.aqua-time.com.ua:article-173
record_format ojs
institution Experimental Oncology
baseUrl_str
datestamp_date 2023-10-11T16:43:26Z
collection OJS
language English
topic Bricker urinary diversion
quality of life
radical cystectomy
ureterocutaneostomy
spellingShingle Bricker urinary diversion
quality of life
radical cystectomy
ureterocutaneostomy
Stakhovskyi, O.E.
Semko, S.L.
Pikul, M.V.
Grechko, B.O.
Voylenko, O.A.
Kononenko, O.A.
Vitruk, I.V.
Stakhovsky, E.O.
Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion
topic_facet Bricker urinary diversion
quality of life
radical cystectomy
ureterocutaneostomy
Bricker urinary diversion
quality of life
radical cystectomy
ureterocutaneostomy
format Article
author Stakhovskyi, O.E.
Semko, S.L.
Pikul, M.V.
Grechko, B.O.
Voylenko, O.A.
Kononenko, O.A.
Vitruk, I.V.
Stakhovsky, E.O.
author_facet Stakhovskyi, O.E.
Semko, S.L.
Pikul, M.V.
Grechko, B.O.
Voylenko, O.A.
Kononenko, O.A.
Vitruk, I.V.
Stakhovsky, E.O.
author_sort Stakhovskyi, O.E.
title Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion
title_short Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion
title_full Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion
title_fullStr Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion
title_full_unstemmed Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion
title_sort quality of life in patients after radical cystectomy with modified ureterocutaneostomy and bricker urinary diversion
title_alt Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion
description Summary. Background: Radical cystectomy (RC) has been used for over 100 years as an effective treatment of muscle invasive bladder cancer (MIBC). However, the main surgical challenge is not only to remove an affected organ but also to replace its functional component — urine diversion. The aim of our work is to study the efficacy of the modified ureterocutaneostomy technique by estimating the quality of life in post-RC patients with MIBC. Materials and Methods: A retrospective analysis of the cases of 40 patients was provided. Two groups were delineated depending on urinary diversion: 20 patients with urinary derivation by the modified ureterocutaneostomy method, and 20 patients — with Bricker conduit. All patients were matched by mean age, gender, American Society of Anesthesiologists status, disease stage and duration. 16 (80%) and 15 (75%) patients from the study and control groups, respectively, passed 3 courses of standard preoperative polychemotherapy with gemcitabine-cisplatin. Quality of life was assessed using the health survey SF-36 form (developed at the US Medical Research Institute), adapted at the National Cancer Institute (Ukraine). Results: Comparing patients after ureterocutaneostomy or Bricker surgery, no statistical discrepancy was noted before surgery and after 3 months. A statistical difference in perioperative parameters was noted only when comparing the surgery duration and length of stay in hospital. Conclusions: The modified ureterocutaneostomy technique contributes to performing surgery faster and more effectively since an intestinal stage is skipped in surgery. Our findings indicate that ureterocutaneostomy technique may be used as a standard of care for post-RC patients with MIBC.
publisher PH Akademperiodyka
publishDate 2023
url https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-10
work_keys_str_mv AT stakhovskyioe qualityoflifeinpatientsafterradicalcystectomywithmodifiedureterocutaneostomyandbrickerurinarydiversion
AT semkosl qualityoflifeinpatientsafterradicalcystectomywithmodifiedureterocutaneostomyandbrickerurinarydiversion
AT pikulmv qualityoflifeinpatientsafterradicalcystectomywithmodifiedureterocutaneostomyandbrickerurinarydiversion
AT grechkobo qualityoflifeinpatientsafterradicalcystectomywithmodifiedureterocutaneostomyandbrickerurinarydiversion
AT voylenkooa qualityoflifeinpatientsafterradicalcystectomywithmodifiedureterocutaneostomyandbrickerurinarydiversion
AT kononenkooa qualityoflifeinpatientsafterradicalcystectomywithmodifiedureterocutaneostomyandbrickerurinarydiversion
AT vitrukiv qualityoflifeinpatientsafterradicalcystectomywithmodifiedureterocutaneostomyandbrickerurinarydiversion
AT stakhovskyeo qualityoflifeinpatientsafterradicalcystectomywithmodifiedureterocutaneostomyandbrickerurinarydiversion
first_indexed 2025-07-17T12:16:07Z
last_indexed 2025-07-17T12:16:07Z
_version_ 1850411077193433088
spelling oai:ojs2.ex.aqua-time.com.ua:article-1732023-10-11T16:43:26Z Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion Stakhovskyi, O.E. Semko, S.L. Pikul, M.V. Grechko, B.O. Voylenko, O.A. Kononenko, O.A. Vitruk, I.V. Stakhovsky, E.O. Bricker urinary diversion, quality of life, radical cystectomy, ureterocutaneostomy Bricker urinary diversion, quality of life, radical cystectomy, ureterocutaneostomy Summary. Background: Radical cystectomy (RC) has been used for over 100 years as an effective treatment of muscle invasive bladder cancer (MIBC). However, the main surgical challenge is not only to remove an affected organ but also to replace its functional component — urine diversion. The aim of our work is to study the efficacy of the modified ureterocutaneostomy technique by estimating the quality of life in post-RC patients with MIBC. Materials and Methods: A retrospective analysis of the cases of 40 patients was provided. Two groups were delineated depending on urinary diversion: 20 patients with urinary derivation by the modified ureterocutaneostomy method, and 20 patients — with Bricker conduit. All patients were matched by mean age, gender, American Society of Anesthesiologists status, disease stage and duration. 16 (80%) and 15 (75%) patients from the study and control groups, respectively, passed 3 courses of standard preoperative polychemotherapy with gemcitabine-cisplatin. Quality of life was assessed using the health survey SF-36 form (developed at the US Medical Research Institute), adapted at the National Cancer Institute (Ukraine). Results: Comparing patients after ureterocutaneostomy or Bricker surgery, no statistical discrepancy was noted before surgery and after 3 months. A statistical difference in perioperative parameters was noted only when comparing the surgery duration and length of stay in hospital. Conclusions: The modified ureterocutaneostomy technique contributes to performing surgery faster and more effectively since an intestinal stage is skipped in surgery. Our findings indicate that ureterocutaneostomy technique may be used as a standard of care for post-RC patients with MIBC. Summary. Background: Radical cystectomy (RC) has been used for over 100 years as an effective treatment of muscle invasive bladder cancer (MIBC). However, the main surgical challenge is not only to remove an affected organ but also to replace its functional component — urine diversion. The aim of our work is to study the efficacy of the modified ureterocutaneostomy technique by estimating the quality of life in post-RC patients with MIBC. Materials and Methods: A retrospective analysis of the cases of 40 patients was provided. Two groups were delineated depending on urinary diversion: 20 patients with urinary derivation by the modified ureterocutaneostomy method, and 20 patients — with Bricker conduit. All patients were matched by mean age, gender, American Society of Anesthesiologists status, disease stage and duration. 16 (80%) and 15 (75%) patients from the study and control groups, respectively, passed 3 courses of standard preoperative polychemotherapy with gemcitabine-cisplatin. Quality of life was assessed using the health survey SF-36 form (developed at the US Medical Research Institute), adapted at the National Cancer Institute (Ukraine). Results: Comparing patients after ureterocutaneostomy or Bricker surgery, no statistical discrepancy was noted before surgery and after 3 months. A statistical difference in perioperative parameters was noted only when comparing the surgery duration and length of stay in hospital. Conclusions: The modified ureterocutaneostomy technique contributes to performing surgery faster and more effectively since an intestinal stage is skipped in surgery. Our findings indicate that ureterocutaneostomy technique may be used as a standard of care for post-RC patients with MIBC. PH Akademperiodyka 2023-05-31 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-10 10.32471/exp-oncology.2312-8852.vol-42-no-3.15047 Experimental Oncology; Vol. 42 No. 3 (2020): Experimental Oncology; 224-227 Експериментальна онкологія; Том 42 № 3 (2020): Експериментальна онкологія; 224-227 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-42-no-3 en https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-10/2020-3-10 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/